Divyaswathi Citla Sridhar, MD MS/LinkedIn
Nov 20, 2025, 13:56
Glanzmann Thrombasthenia Is More Common Than Previously Thought
Divyaswathi Citla Sridhar, Pediatric Hematologist and Oncologist at Arkansas Children’s Hospital, shared a post on LinkedIn:
”Our analysis of 1,059 U.S. patients with Glanzmann Thrombasthenia (GT) shows that GT prevalence may be significantly higher in the United States than previously recognized, and underscores the substantial clinical burden from recurrent bleeding, anemia, and transfusion dependence.
Huge shout-out to my fantastic collaborator, Daniel Liu, for his expertise in working with this complex dataset.”
Read the full article here.
Title: Characterising Glanzmann Thrombasthenia in the United States: Real-World Data From the EPIC Cosmos Dataset
Authors: Divyaswathi Citla-Sridhar, Daniel Liu

Stay updated with Hemostasis today.
Arkansas Children’s Hospital
bleeding disorders
Daniel Liu
Divyaswathi Citla-Sridhar
EPIC Cosmos Dataset
Glanzmann thrombasthenia
Glanzmann Thrombasthenia Support Group
Glanzmann's Research Foundation
haemophilia
Health
Hematology
Hemostasis
Hemostasis Today
Inherited Bleeding Disorder
Medicine
thrombosis
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia
